Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing

BACKGROUND: Detection of circulating cell-free DNA (cfDNA) has potential clinical value for assessing tumor biology in patients with hepatocellular carcinoma (HCC), yet many traditional assays lack robustness. This study was the first to apply a high-throughput sequencing platform to detect tumor-as...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Wenjun, Yang, Huayu, Xu, Haifeng, Wang, Yanan, Ge, Penglei, Ren, Jinjun, Xu, Wei, Lu, Xin, Sang, Xinting, Zhong, Shouxian, Zhang, Hongbing, Mao, Yilei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130021/
https://www.ncbi.nlm.nih.gov/pubmed/27248174
http://dx.doi.org/10.18632/oncotarget.9629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130021/
https://www.ncbi.nlm.nih.gov/pubmed/27248174
http://dx.doi.org/10.18632/oncotarget.9629

Ejemplares similares